EPTIS
BAM Logo

AU-18 Calprotectin

[AU-18 Calprotectina]

EPTIS factsheet 415846 | Last revision 2017-09-16 | URL: https://www.eptis.bam.de/pts415846 https://www.eptis.bam.de/pts415846

PT provider
PT provider GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology) GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Based in Spain
Language(s) Spanish / English
Remarks Fecal calprotectin is usually elevated in inflammatory bowel diseases, coeliac disease, infectious colitis, necrotizing enterocolitis, intestinal cystic fibrosis and colorectal cancer
Keywords
Product groups Health care / medical devices
Human test material
Laboratory / scientific equipment
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human faeces Calprotectin -
-
Calprotectin (qual.) -
-
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards GECLID follows guidelines within ISO 17043 & ISO15328
Additional, subsidiary aims
Number of participants 25
Accredited or otherwise reviewed by a 3rd party

ISO 9001 certificated

Operation is commissioned / requested by Spanish Society for Immunology
Fees and frequency
Participation fee 137,5 EU
Regularly operated Yes (Twice a year)
Year of first operation 2017
Contact details of the PT provider
Provider Contact person
GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Pº de Filipinos s/n
47007 Valladolid
Spain

Phone: +34 983 41 88 23 Ext.89673
Fax:
Web: https://www.geclid.es https://www.geclid.es
Dr. Carmen Martin
Phone: +34 686 247 331
Fax:
Email: responsable@geclid.es responsable@geclid.es
If you find any mistakes please contact the responsible EPTIS coordinator in Spain, Mr Miquel Navarro. Mr Miquel Navarro.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21